Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
and was discovered by an imaging-based screen
PF 1022A (1-100 μg/mL) completely inhibits larval movement at most examination points
In vivo CUDC-101 promotes tumor regression in various cancer xenograft models such as non-small cell lung cancer (NSCLC)
Karlsson JJ
Varenicline (CP 526555) (subcutaneous injection
ISX9 - Neurogenic Modulator. CAS# 832115-62-5 0249 and was discovered by anISX9, CAS No. 832115 62 5, is a neurogenic modulator. It mediates neuroD reporter gene induction via activation of Ca2+ influx, and increases expression of neurogenic differentiation 1 (NeuroD1) transcription factor. It induces neuronal differentiation in human cortical neuronal cells (HCN), adult mouse whole brain (MWB) and subventricular zone (SVZ) progenitors. ISX9 is also shown to induce cardiomyogenic differentiation of Notch activated epicardium